Who's buying Olema Pharmaceuticals, Inc.?

OLMA insider buying, 13F and 13D filings

• Oct 16, 202613D stake (no activist plan)
  BIOTECHNOLOGY VALUE FUND L P (+10): Amended Schedule 13D: 9.8% stake
  Item 4 is hereby amended to add the following: Effective October 14, 2026, Dr. Gorjan Hrustanovic resigned from the Board. Dr. Hrustanovic also resigned from the Compensation Committee of the Board and the Science and Technology Committee of the Board. Dr. Hrustanovic's resignati…
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.